{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:39Z","timestamp":1761540339929},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2001,3,1]]},"DOI":"10.1038\/sj.gt.3301409","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T16:57:55Z","timestamp":1031158675000},"page":"354-361","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Intravenous administration of an E1\/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL\/6 mice"],"prefix":"10.1038","volume":"8","author":[{"given":"PA","family":"Fields","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JN","family":"Hagstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VR","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ML","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JP","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KA","family":"High","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RW","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,4,18]]},"reference":[{"key":"BF3301409_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-4613-0331-2_3","volume":"386","author":"LW Hoyer","year":"1995","unstructured":"Hoyer LW . The incidence of factor VIII inhibitors in patients with severe hemophilia A Adv Exp Med Biol 1995 386: 35\u201346","journal-title":"Adv Exp Med Biol"},{"key":"BF3301409_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-4613-0331-2_6","volume":"386","author":"KA High","year":"1995","unstructured":"High KA . Factor IX: molecular structure, epitopes, and mutations associated with inhibitor formation Adv Exp Med Biol 1995 386: 79\u201386","journal-title":"Adv Exp Med Biol"},{"key":"BF3301409_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1055\/s-0037-1615877","volume":"82","author":"RW Herzog","year":"1999","unstructured":"Herzog RW, High KA . AAV-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy Thr Haemost 1999 82: 540\u2013546","journal-title":"Thr Haemost"},{"key":"BF3301409_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00062752-199809000-00003","volume":"5","author":"RW Herzog","year":"1998","unstructured":"Herzog RW, High KA . Problems and prospects in gene therapy for hemophilia Curr Opin Hematol 1998 5: 321\u2013326","journal-title":"Curr Opin Hematol"},{"key":"BF3301409_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/73464","volume":"24","author":"MA Kay","year":"2000","unstructured":"Kay MA et al. Evidence for gene transfer and expression of blood coagulation factor IX in patients with severe hemophilia B treated with an AAV vector Nat Genet 2000 24: 257\u2013261","journal-title":"Nat Genet"},{"key":"BF3301409_CR6","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1073\/pnas.91.6.2353","volume":"91","author":"MA Kay","year":"1994","unstructured":"Kay MA et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs Proc Natl Acad Sci USA 1994 91: 2353\u20132357","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301409_CR7","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1182\/blood.V94.12.3968.424k43_3968_3975","volume":"94","author":"JN Lozier","year":"1999","unstructured":"Lozier JN, Metzger ME, Donahue RE, Morgan RA . Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose limiting toxicity Blood 1999 94: 3968\u20133975","journal-title":"Blood"},{"key":"BF3301409_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ng1293-397","volume":"5","author":"TAG Smith","year":"1994","unstructured":"Smith TAG et al. Adenovirus-mediated expression of therapeutic plasma levels of human factor IX in mice Nat Genet 1994 5: 397\u2013402","journal-title":"Nat Genet"},{"key":"BF3301409_CR9","first-page":"217","volume":"3","author":"B Fang","year":"1996","unstructured":"Fang B et al. Lack of persistence of E1\u2212 recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dog Gene Therapy 1996 3: 217\u2013222","journal-title":"Gene Therapy"},{"key":"BF3301409_CR10","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1182\/blood.V88.10.3846.bloodjournal88103846","volume":"88","author":"S Connelly","year":"1996","unstructured":"Connelly S et al. Complete short-term correction of canine hemophilia A by in vivo gene therapy Blood 1996 88: 3846\u20133853","journal-title":"Blood"},{"key":"BF3301409_CR11","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1073\/pnas.93.7.3056","volume":"93","author":"J Walter","year":"1996","unstructured":"Walter J et al. Successful expression of human factor IX following repeat administration of an adenoviral vector in mice Proc Natl Acad Sci USA 1996 93: 3056\u20133061","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301409_CR12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood.V91.3.784","volume":"91","author":"J Kung","year":"1998","unstructured":"Kung J et al. Human F.IX corrects the bleeding diathesis of mice with hemophilia B Blood 1998 91: 784\u2013790","journal-title":"Blood"},{"key":"BF3301409_CR13","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V91.9.3273","volume":"91","author":"S Connelly","year":"1998","unstructured":"Connelly S et al. Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy Blood 1998 91: 3273\u20133281","journal-title":"Blood"},{"key":"BF3301409_CR14","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1073\/pnas.92.16.7257","volume":"92","author":"Y Yang","year":"1995","unstructured":"Yang Y, Xiang Z, Ertl HCJ, Wilson JM . Upregulation of class I major histocompatibility complex antigens by interferon \u03b3 is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo Proc Natl Acad Sci USA 1995 92: 7257\u20137261","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301409_CR15","first-page":"137","volume":"3","author":"Y Yang","year":"1996","unstructured":"Yang Y et al. Immune response to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo Gene Therapy 1996 3: 137\u2013144","journal-title":"Gene Therapy"},{"issue":"Suppl. 1","key":"BF3301409_CR16","first-page":"656a","volume":"88","author":"J Qian","year":"1996","unstructured":"Qian J, Bi L, Kazazian HH, Hoyer LW . Inhibitor development and T cell response to human factor VIII in murine hemophilia A Blood 1996 88 (Suppl. 1): 656a","journal-title":"Blood"},{"key":"BF3301409_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/mthe.2000.0032","volume":"1","author":"PA Fields","year":"2000","unstructured":"Fields PA et al. Choice of vector determines T cell subsets involved in immune responses against the secreted transgene product factor IX Molec Ther 2000 1: 225\u2013235","journal-title":"Molec Ther"},{"key":"BF3301409_CR18","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.94.11.5804","volume":"94","author":"RW Herzog","year":"1997","unstructured":"Herzog RW et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus Proc Natl Acad Sci USA 1997 94: 5804\u20135809","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301409_CR19","first-page":"A655","volume":"13","author":"ML Murphy","year":"1999","unstructured":"Murphy ML, Wille U, Hunter CA, Farrell JP . IL-10 deficient mice are resistant to Leishmania donovani infection FASEB J 1999 13: (Suppl. S) A655","journal-title":"FASEB J"},{"key":"BF3301409_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/sj.gt.3300412","volume":"4","author":"A Michou","year":"1997","unstructured":"Michou A et al. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression Gene Therapy 1997 4: 473\u2013482","journal-title":"Gene Therapy"},{"key":"BF3301409_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2144\/96202rr05","volume":"20","author":"M-JTFD Vrancken Peeters","year":"1996","unstructured":"Vrancken Peeters M-JTFD, Lieber A, Perkins J, Kay MA . Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer BioTechniques 1996 20: 278\u2013285","journal-title":"BioTechniques"},{"key":"BF3301409_CR22","first-page":"151","volume":"2","author":"D Barr","year":"1995","unstructured":"Barr D et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains Gene Therapy 1995 2: 151\u2013155","journal-title":"Gene Therapy"},{"key":"BF3301409_CR23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1089\/10430349950017455","volume":"10","author":"L Pastore","year":"1999","unstructured":"Pastore L et al. Use of liver-specific promoter reduces immune response to the transgene in adenoviral vectors Hum Gene Ther 1999 10: 1773\u20131781","journal-title":"Hum Gene Ther"},{"key":"BF3301409_CR24","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.72.5.4212-4223.1998","volume":"72","author":"K Jooss","year":"1998","unstructured":"Jooss K, Yang Y, Fisher KJ, Wilson JM . Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers J Virol 1998 72: 4212\u20134223","journal-title":"J Virol"},{"key":"BF3301409_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"RD Waal Malefyt","year":"1991","unstructured":"Waal Malefyt RD et al. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J Exp Med 1991 174: 1209\u20131220","journal-title":"J Exp Med"},{"key":"BF3301409_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1084\/jem.184.1.19","volume":"184","author":"H Groux","year":"1996","unstructured":"Groux H, Bigler M, Roncaralo MG . Interleukin 10 induces a long-term antigen-specific anergic state in human CD4+ T cells J Exp Med 1996 184: 19\u201329","journal-title":"J Exp Med"},{"key":"BF3301409_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1084\/jem.187.2.177","volume":"187","author":"J Buer","year":"1998","unstructured":"Buer J et al. Interleukin-10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo J Exp Med 1998 187: 177\u2013183","journal-title":"J Exp Med"},{"key":"BF3301409_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/hep.510270116","volume":"27","author":"PA Knolle","year":"1998","unstructured":"Knolle PA et al. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells Hepatology 1998 27: 93\u201399","journal-title":"Hepatology"},{"key":"BF3301409_CR29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/JVI.72.1.180-190.1998","volume":"72","author":"P Loeser","year":"1998","unstructured":"Loeser P, Jennings GS, Strauss M, Sandig V . Reactivation of the previously silenced cytomegalovirus major immediate\u2013early promoter in the mouse liver: involvement of NF\u03baB J Virol 1998 72: 180\u2013190","journal-title":"J Virol"},{"key":"BF3301409_CR30","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1096\/fasebj.6.10.1634046","volume":"6","author":"RP Vemuru","year":"1992","unstructured":"Vemuru RP et al. Immune tolerance to a defined heterologous antigen after intrasplenic hepatocyte transplantation \u2013 implications for gene therapy FASEB J 1992 6: 2836\u20132842","journal-title":"FASEB J"},{"key":"BF3301409_CR31","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1182\/blood.V91.12.4600","volume":"91","author":"H Nakai","year":"1998","unstructured":"Nakai H et al. AAV-mediated gene transfer of human blood coagulation factor IX into mouse liver Blood 1998 91: 4600\u20134607","journal-title":"Blood"},{"key":"BF3301409_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/ng0797-270","volume":"16","author":"RO Snyder","year":"1997","unstructured":"Snyder RO et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors Nat Genet 1997 16: 270\u2013276","journal-title":"Nat Genet"},{"key":"BF3301409_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/4751","volume":"5","author":"RO Snyder","year":"1999","unstructured":"Snyder RO et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors Nat Med 1999 5: 64\u201370","journal-title":"Nat Med"},{"key":"BF3301409_CR34","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.1006\/mthe.2000.0181","volume":"1","author":"A Nathwani","year":"2000","unstructured":"Nathwani A, Davidoff AM, Hanawa H, Nienhuis AW . The site of rAAV-mediated F.IX expression can significantly influence the level of expression and immunological response to the transgene product Mol Ther 2000 1: S287","journal-title":"Mol Ther"},{"key":"BF3301409_CR35","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V95.5.1594.005k34_1594_1599","volume":"95","author":"H Chao","year":"2000","unstructured":"Chao H, Mao L, Bruce AT, Walsh CE . Sustained expression of human factor VIII in mice using a parvovirus-based vector Blood 2000 95: 1594\u20131599","journal-title":"Blood"},{"key":"BF3301409_CR36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V95.3.820.003k32_820_828","volume":"95","author":"C Balague","year":"2000","unstructured":"Balague C et al. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector Blood 2000 95: 820\u2013828","journal-title":"Blood"},{"key":"BF3301409_CR37","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V96.3.1173.015k34_1173_1176","volume":"96","author":"F Park","year":"2000","unstructured":"Park F, Ohashi K, Kay MA . Therapeutic levels of human factor VIII and IX using HIV-based lentiviral vectors in mouse liver Blood 2000 96: 1173\u20131176","journal-title":"Blood"},{"key":"BF3301409_CR38","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1089\/10430349950016401","volume":"10","author":"T Brann","year":"1999","unstructured":"Brann T et al. Adenoviral vector-mediated expression of physiological levels of human factor VIII in non-human primates Hum Gene Ther 1999 10: 2999\u20133011","journal-title":"Hum Gene Ther"},{"key":"BF3301409_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/71673","volume":"24","author":"F Park","year":"2000","unstructured":"Park F et al. Efficient lentiviral transduction of liver requires cell cycling in vivo Nat Genet 2000 24: 49\u201352","journal-title":"Nat Genet"},{"key":"BF3301409_CR40","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/sj.gt.3300680","volume":"5","author":"T Matsushita","year":"1998","unstructured":"Matsushita T . Adeno-associated virus vector can be efficiently produced without helper virus Gene Therapy 1998 5: 938\u2013945","journal-title":"Gene Therapy"},{"key":"BF3301409_CR41","unstructured":"Matsushita T, Godwin S, Surosky R, Colosi P . Improvements in AAV vector production: elimination of pseudo-wild-type AAV Proc 2nd Ann Am Soc Gene Therapy. Washington, DC 1999 p 2a"},{"key":"BF3301409_CR42","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1182\/blood.V95.8.2536","volume":"95","author":"JN Hagstrom","year":"2000","unstructured":"Hagstrom JN et al. Enhanced muscle-derived expression of coagulation factor IX from a skeletal actin\/CMV hybrid promoter Blood 2000 95: 2536\u20132542","journal-title":"Blood"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301409","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:24:06Z","timestamp":1648603446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,3,1]]}},"alternative-id":["BF3301409"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301409","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,1]]},"assertion":[{"value":"21 August 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}